Mumbai Civic Body Seeks Centre's Permission to Conduct Covaxin Trials on 12-18 Age Group
Active Times For Printing Download Epaper from files section from bottom of this page
Mumbai: The Brihanmumbai Municipal Corporation has written to the Central government seeking permission to conduct trials of Bharat Biotech’s vaccine Covaxin on children of 12-18 ages. Speaking to CNN-News18, Additional Municipal Commissioner Suresh Kakani on Friday said, “We have conveyed our willingness to conduct trials in kids aged between 12-18. We are awaiting a nod from that agency so that we can take it forward. We have to take permission from the ethics committee, once the nod is given." The move comes after vaccine companies wrote to BMC for the trials, he said. On the question of where the trials will be conducted, he said, “As of now, we have conveyed willingness of the two medical college hospitals and, we are not aware of the sample size, but we definitely go by the ICMR’s guidelines." Meanwhile, Patna’s All India Institute of Medical Sciences (AIIMS) has started the paediatric trials for Covaxin after Bharat Biotech received the nod from the Drugs Controller General of India (DCGI) for clinical trials on May 11. AIIMS Delhi is also planning to start paediatric clinical trials of Covaxin in the coming day, news agency ANI reported. Earlier, VK Paul, Member (Health), Niti Aayog had said, “Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years."
